Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Scott B Baver"'
Autor:
Joy I Lee, Patricia J Sollars, Scott B Baver, Gary E Pickard, Mindy Leelawong, Gregory A Smith
Publikováno v:
PLoS Pathogens, Vol 5, Iss 4, p e1000387 (2009)
The neuroinvasive property of several alpha-herpesviruses underlies an uncommon infectious process that includes the establishment of life-long latent infections in sensory neurons of the peripheral nervous system. Several herpesvirus proteins are re
Externí odkaz:
https://doaj.org/article/d91db4e36f764fb487b797490dbebd05
Publikováno v:
PLoS ONE, Vol 4, Iss 3, p e4984 (2009)
Retinal ganglion cells that express the photopigment melanopsin are intrinsically photosensitive (ipRGCs) and exhibit robust synaptically driven ON-responses to light, yet they will continue to depolarize in response to light when all synaptic input
Externí odkaz:
https://doaj.org/article/39f4a50d92484d3bb53031d4388d85d6
Autor:
David Dingli, Joana E. Matos, Kerri Lehrhaupt, Sangeeta Krishnan, Michael Yeh, Jesse Fishman, Sujata P. Sarda, Scott B. Baver
Publikováno v:
Annals of Hematology
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and life-threatening disease with symptoms of hemolysis and thrombosis. Current therapies for this complement-mediated disease rely predominantly on inhibition of the C5 complement protein. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22cbf05f538f76dee01e531cb7847dea
http://europepmc.org/articles/PMC8720163
http://europepmc.org/articles/PMC8720163
Autor:
Sangeeta Krishnan, Sujata P. Sarda, Natalia Swartz, Christopher W. Yee, Sanjana Sundaresan, Colin Kunzweiler, Mei Sheng Duh, Scott B. Baver, Rachel H. Bhak, Nikita Mody-Patel
INTRODUCTION Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hematological disease characterized by complement-mediated hemolysis, resulting in anemia, thrombosis, and bone marrow failure. Currently available treatment options for PNH i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08d22e1a19006d18ec6bfc3c6826a8b7
Autor:
Alexander Röth, Mohamed Hamdani, David Cella, Ray Hsieh, Shannon Shaffer, Sujata P. Sarda, William R. Lenderking, Scott B. Baver
Publikováno v:
Blood. 136:4-5
BACKGROUND Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired, life-threatening hematologic disease characterized by complement-mediated hemolysis resulting in anemia, thrombosis, and bone marrow failure. The PEGASUS phase 3 randomized stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0735dbe9ef77ac72c9ec9c4a3c2e44f
https://doi.org/10.1182/blood-2020-142354
https://doi.org/10.1182/blood-2020-142354
Autor:
Antonio M. Risitano, Jean-Jacques Kiladjian, Temitayo Ajayi, Ilene C. Weitz, Mohamed Hamdani, Régis Peffault de Latour, Carlos M. de Castro, Morag Griffin, Hisakazu Nishimori, Scott B. Baver
Publikováno v:
Blood. 136:44-45
INTRODUCTION Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired, clonal, nonmalignant hematologic disease characterized by complement-mediated red blood cell hemolysis. The current standard of care for patients with PNH is C5 inhibition. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9962d7ac7ce232033a8e6cab78ec2203
https://doi.org/10.1182/blood-2020-142166
https://doi.org/10.1182/blood-2020-142166
Autor:
David Dingli, Sangeeta Krishnan, Joana E. Matos, Kerri Lehrhaupt, Scott B. Baver, Sujata P. Sarda
Publikováno v:
Blood. 136:2-2
INTRODUCTION Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired, hematologic disease characterized by chronic complement-mediated hemolysis. Treatment with the C5 inhibitor eculizumab has resulted in a reduction in intravascular hemolysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::425f4d90d517452ab27d8be2c8a33e4c
https://doi.org/10.1182/blood-2020-141844
https://doi.org/10.1182/blood-2020-141844
Autor:
Joana E. Matos, Sangeeta Krishnan, David Dingli, Sujata P. Sarda, Scott B. Baver, Kerri Lehrhaupt
Publikováno v:
Blood. 136:3-3
INTRODUCTION Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired, hematologic disease characterized by chronic complement-mediated hemolysis. Treatment with the C5 inhibitor eculizumab has resulted in a reduction in intravascular hemolysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0349456b769724c46acdcb9c597875c8
https://doi.org/10.1182/blood-2020-142327
https://doi.org/10.1182/blood-2020-142327
Autor:
Shannon Guyot, Kevin A. Hope, Scott B. Baver, Christian Bjørbæk, Catherine C. Kaczorowski, Kristen M.S. O'Connell
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience. 34(16)
The hypothalamic arcuate nucleus (ARH) is a brain region critical for regulation of food intake and a primary area for the action of leptin in the CNS. In lean mice, the adipokine leptin inhibits neuropeptide Y (NPY) and agouti-related peptide (AgRP)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c814da42ea45b0d5fb0fde86e76454ea
https://pubmed.ncbi.nlm.nih.gov/24741039
https://pubmed.ncbi.nlm.nih.gov/24741039
Publikováno v:
Biophysical Journal. 104(2)
The adipostat leptin binds the long-isoform of the leptin receptor (LepRb) signaling nutritional status in mammals. The hypothalamic arcuate nucleus (ARH) is a major brain region involved in the regulation of food intake; LepRb are highly expressed i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2804f5be0b741210755526a3e7fac0e0